The follow-up study included 153 former BeSt participants (median 20 years post-enrollment) and 282 former IMPROVED participants (median 12 years post-enrollment).
The follow-up study included 153 former BeSt participants (median 20 years post-enrollment) and 282 former IMPROVED participants (median 12 years post-enrollment).
Investigators found some sex-specific differences in incident gout appear to be significantly associated to the type as well as the amount of alcohol consumed .
Investigators found some sex-specific differences in incident gout appear to be significantly associated to the type as well as the amount of alcohol consumed .
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Gout flare prophylaxis with colchicine was associated with a lower rate of cardiovascular events for up to the next 180 days compared with no prophylaxis.
Using data from electronic medical records, a tool to alert caregivers in emergency departments to possible flares of gout showed “modest” predictive value.
Using data from electronic medical records, a tool to alert caregivers in emergency departments to possible flares of gout showed “modest” predictive value.
The Psoriasis Epidemiology Screening Tool (PEST) can help identify patients with psoriasis at higher risk of developing psoriatic arthritis. Do you know the key indicator? Take our quiz to find out!
The Psoriasis Epidemiology Screening Tool (PEST) can help identify patients with psoriasis at higher risk of developing psoriatic arthritis. Do you know the key indicator? Take our quiz to find out!
Research found older age, historical fracture, and opioid use to be associated with higher odds of fracture in Medicare beneficiaries with ankylosing spondylitis.
Research found older age, historical fracture, and opioid use to be associated with higher odds of fracture in Medicare beneficiaries with ankylosing spondylitis.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.